A shadow economy for unlicensed weight-loss drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Drug Acquiring Popularity Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving discount codes.
Thriving Commerce on Messaging Platforms
Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Vendors promote the substance there before directing customers to other platforms for transactions.
Learning About The Experimental Drug
This medication is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist patients lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed digitally as the next Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have warned that the sale of what is still an unapproved medication in the UK is worrisome and could result in users injecting substances of unknown origin.
Some experts stated the demand for the experimental drug could be linked to the increasing cost of approved weight loss treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer laws, potentially leading to fines, prosecution or imprisonment.
Platform Reaction and Content Elimination
Based on the social media company, the platform has removed violative material and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Investigations also discovered groups with up to 9,000 participants selling retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of users, filled with images of weight loss, positive testimonials and detailed instructions for mixing or injecting at home.
After moments of entering one community, a vendor posted contact information, where the majority of transactions take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None inquired about body mass, health issues or previous experience.
Product Information and Costs
Within these groups, posts show dark colored parcels with Royal Mail stickers, stating to contain fresh supplies. One message read: “It took eight of us to load them this morning.”
Customers can select between powder vials, mixed at home with sterile water, or pre-filled injectors usually priced at £160 for 20mg. When asked how much time a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are administering substances they can’t verify. Even if the science behind this drug is valid, these online products may not contain what they advertise,” said a pharmacy expert, the director of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the increase in demand to current cost increases for approved slimming medications such as Mounjaro. “With prices increasing, patients are turning to social media. But counterfeit treatments are highly risky. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.
Her team has previously encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they explained, adding that any item “falsely representing itself as a company experimental product not yet approved … may expose patients to possibly serious medical dangers”.
